ScholarIQanswers from OpenAlex

RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial

PaperCitations, authors & open-access status

RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial have?

ScholarIQcitation count

RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial has 32 citations in the OpenAlex counts ScholarIQ stores.

When was RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial published?

ScholarIQyear

RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial has 2019 year in the ScholarIQ index.

What is the open-access status of RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial?

ScholarIQoa status

RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial has closed oa status in the ScholarIQ index.

What is the DOI of RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial?

ScholarIQdoi

The DOI for RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial is on the source record.

What is the PMID of RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial?

ScholarIQpmid

The PMID for RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial is on the source record.

What is the OpenAlex record for RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial?

ScholarIQopenalex

The OpenAlex for RETRACTED ARTICLE: Effect of empiric intravenous intralipid therapy on pregnancy outcome in women with unexplained recurrent implantation failure undergoing intracytoplasmic sperm injection-embryo transfer cycle: a randomized controlled trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial